Scorpius Holdings, Inc. (SCPX)
0.0010
0.00 (0.00%)
USD |
OTCM |
Dec 22, 15:47
Scorpius Holdings EPS Diluted (Quarterly): -1.162 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncology Pharma, Inc. | -- |
| Trevena, Inc. | -5.792 |
| Cantabio Pharmaceuticals, Inc. | -- |
| Q BioMed, Inc. | -- |
| Syros Pharmaceuticals, Inc. | -0.1626 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.29M |
| Revenue (Quarterly) | 0.2123M |
| Total Expenses (Quarterly) | 10.93M |
| Enterprise Value | 15.32M |
| Gross Profit Margin (Quarterly) | -862.2% |
| Profit Margin (Quarterly) | -5.32K% |
| Earnings Yield | -2.99M% |
| Normalized Earnings Yield | -2.983M |